Journal of Neuroscience · 2010 · 126 citations · 37 references
Life SciencesNeurobiologyNeuroscienceMolecular NeuroscienceNeuropharmacologyNeuropsychiatryAttention-deficit/hyperactivity DisorderDopaminergic SignalingNeurotransmissionNeurotransmitter SystemsReward PathwaysSynaptic TransmissionAdhd NeurobiologyD2-like Dopamine ReceptorsDopamine D2-like ReceptorsDopamine Receptor SubtypesDopamine Transporter InhibitionDopamine TransportersPhosphorylation-dependent RegulationTonic Inhibition
The neurotransmitter dopamine (DA) modulates brain circuits involved in attention, reward, and motor activity. Synaptic DA homeostasis is primarily controlled via two presynaptic regulatory mechanisms, DA D(2) receptor (D(2)R)-mediated inhibition of DA synthesis and release, and DA transporter (DAT)-mediated DA clearance. D(2)Rs can physically associate with DAT and regulate DAT function, linking DA release and reuptake to a common mechanism. We have established that the attention-deficit hyperactivity disorder-associated human DAT coding variant Ala559Val (hDAT A559V) results in anomalous DA efflux (ADE) similar to that caused by amphetamine-like psychostimulants. Here, we show that tonic activation of D(2)R provides support for hDAT A559V-mediated ADE. We determine in hDAT A559V a pertussis toxin-sensitive, CaMKII-dependent phosphorylation mechanism that supports D(2)R-driven DA efflux. These studies identify a signaling network downstream of D(2)R activation, normally constraining DA action at synapses, that may be altered by DAT mutation to impact risk for DA-related disorders.
37
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Bruno Giros, Mohamed Jaber, Sara R. Jones et al. · Nature · 1996 · 2.5K citations